The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030, predicts Roots Analysis

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.”

For more information please click on the following
https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:
A detailed assessment of the current market landscape of companies offering drug repurposing services.
Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs.
An analysis of the partnerships that have been established in this domain, in the recent past.
An analysis of the initiatives of big biopharma players engaged in this domain.
A detailed analysis of more than 1,700 terminated / withdrawn / suspended clinical studies of the drug candidates.
A detailed analysis on the cost saving potential of drug repurposing approaches, as compared to the traditional de novo drug development methods.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Type of Repurposing Approaches
Disease-centric approach
Target-centric approach
Drug-centric approach
Therapeutic Area
Same Therapeutic Area
Different Therapeutic Area
Type of Drug Molecule
Biologics
Small Molecule
Key Geographical Region
North America
Europe
Asia-Pacific

Key companies covered in the report
Auxillis Pharma
ChemBio Discovery Solutions
Excelra
GVK Bio
Iris Pharma
Lantern Pharma
PanXome
Pharmacelera
Physiogenex
Smart Pharma
Socium
SOM Biotech

For more information please click on the following
https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

Other Recent Offerings
1. Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030
2. China Biopharmaceutical Contract Manufacturing Market, 2020-2030
3. Antibody Contract Manufacturing Market, 2020 - 2030

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

This release was published on openPR.